The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: vancomycin     Quarter: 2016Q3

Total Records: 1,050     Number of Pages: 53

DRUGNAME PT EventCount
VANCOMYCIN Respiratory distress 3
VANCOMYCIN Respiratory failure 3
Vancomycin Swelling 3
VANCOMYCIN Swelling face 3
Vancomycin Tenderness 3
VANCOMYCIN Trichosporon infection 3
Vancomycin Urinary tract infection 3
Vancomycin Wheezing 3
VANCOMYCIN White blood cell count decreased 3
VANCOMYCIN /00314402/ Pyrexia 3
VANCOMYCIN (MANUFACTURER UNKNOWN) Renal tubular necrosis 3
VANCOMYCIN (MANUFACTURER UNKNOWN) Stevens-Johnson syndrome 3
VANCOMYCIN (MANUFACTURER UNKNOWN) Toxic epidermal necrolysis 3
Vancomycin (Unknown) Pathogen resistance 3
VANCOMYCIN HCL Bacterial infection 3
VANCOMYCIN HCL Decubitus ulcer 3
VANCOMYCIN HCL Drug resistance 3
VANCOMYCIN HCL Dyspnoea 3
VANCOMYCIN HCL Enterocolitis haemorrhagic 3
VANCOMYCIN HCL Fall 3

Total Records: 1,050     Number of Pages: 53